CoChat

Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases

Open access
Marchetto, M. C. N., Winner, B., Gage, F. H. · 2010 · Human Molecular Genetics

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Abstract

Most of our current knowledge about cellular phenotypes in neurodevelopmental and neurodegenerative diseases in humans was gathered from studies in postmortem brain tissues. These samples often represent the end-stage of the disease and therefore are not always a fair representation of how the disease developed. Moreover, under these circumstances, the pathology observed could be a secondary effect rather than the authentic disease cellular phenotype. Likewise, the rodent models available do not always recapitulate the pathology from human diseases. In this review, we will examine recent literature on the use of induced pluripotent stem cells to model neurodegenerative and neurodevelopmental diseases. We highlight the characteristics of diseases like spinal muscular atrophy and familial dysautonomia that allowed partial modeling of the disease phenotype. We review human stem cell literature on common neurodegenerative late-onset diseases such as Parkinson's disease and amyotrophic lateral sclerosis where patients' cells have been successfully reprogrammed but a disease phenotype has not yet been described. So far, the technique is of great interest for early onset monogenetic neurodevelopmental diseases. We speculate about potential further experimental requirements and settings for reprogrammed neurons for in vitro disease modeling and drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq159

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Research works printed but not linked: 2

  1. 2000, 28, 31
  2. 2007, 56, 422

Cited by

See all 168

Metadata

Authors
Marchetto, M. C. N., Winner, B., & Gage, F. H.
Affiliations
Salk Institute for Biological Studies (US)
Venue
Human Molecular Genetics
Published
2010-04-15
Volume
19
Issue
R1
Pages
R71-R76
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2167639593
Cited by
152
References
85
Citations by year
2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 21 · 2015: 9 · 2014: 14 · 2013: 23 · 2012: 14
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Christopher and Dana Reeve Foundation
  • Alexander von Humboldt-Stiftung
  • California Institute of Regenerative Medicine
  • G. Harold and Leila Y. Mathers Foundation
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
induced pluripotent stem cells, disease modeling, neurodegenerative diseases, neurodevelopmental disorders, spinal muscular atrophy, familial dysautonomia, Parkinson's disease, amyotrophic lateral sclerosis, in vitro disease model, drug discovery
MeSH terms
Drug Evaluation, Preclinical, Humans, Neurodegenerative Diseases, Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. https://app.cochat.ai/papers/10.1093/hmg/ddq159
The paper
Marchetto, M. C. N., Winner, B., & Gage, F. H. (2010). Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq159

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.